That's right Bala.
A little DD goes a long way.
The extra AS is to cover any future financing needs for the cost of mergers and acquisitions that are gonna take VRUS to uplist territory. That's in the filings.
If anyone is concerned about the AS, go on OTC markets and look up CRON and its share structure.
One will find that the AS for CRON is UNLIMITED.
YES, literally UNLIMITED.
The SP of CRON went up to the $20+ range recently..
Our OS is 10x higher than CRON.
But if you do the math, $20-$25 divided by 10 equals about $2-$2.50. CRON deals with MJ/CBD
VRUS currently has European and Middle Eastern distribution contracts and a huge backlog of orders that are being filled now.
VRUS has also stated that they are working on distribution of consumer goods for the North American market next.
Andrew Garnocks other companies have "consumer goods" that could benefit from distribution to the North American market and the international market too.
The European Union imports a lot of MJ/CBD from North America/Canada already, and VRUS is the perfect middle man, and could potentially get above the $2-2.50 target based on the fact that it could/would have a more diverse product list than just MJ/CBD as CRON has.
Company has stated that they plan to uplist organically without a RS, and it could be entirely possible if all of the aforementioned is considered.
With all the DD that has been done here and the fact that Andrew Garnock is heavily invested her, coupled with the fact that he was instrumental in taking CRON to Nasdaq, one would have to be lacking in intellect to not see where this ticker is going. Uplist scheduled by the fall of 2019 and that means we will be rocketing to the uplist target price shortly.
VRUS is gonna make a lot of people fairly wealthy.
VRUS FTW
